We are live on ! Find out more
GRCE

Grace Therapeutics
GRCE

15 hedge funds and large institutions have $255K invested in Grace Therapeutics in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

0% more ownership

Funds ownership: 0.07% → 0.08% (+0%)

12% less funds holding

Funds holding: 17 → 15 (-2)

35% less capital invested

Capital invested by funds: $391K → $255K (-$137K)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$39.7K
2
Bank of America
Bank of America
North Carolina
+$30.1K
3
Morgan Stanley
Morgan Stanley
New York
+$27.9K
4
Koshinski Asset Management
Koshinski Asset Management
Illinois
+$3K
5
TSS
Two Sigma Securities
New York
+$2.03K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$73K
2
VF
Virtu Financial
New York
-$54K
3
EDRH
Edmond de Rothschild Holding
Switzerland
-$25K
4
UBS Group
UBS Group
Switzerland
-$9K
5
Jane Street
Jane Street
New York
-$776
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$88K +$39.7K +4,395 +61%
Morgan Stanley
2
Morgan Stanley
New York
$42K +$27.9K +3,097 +126%
Bank of America
3
Bank of America
North Carolina
$26K +$30.1K +3,333 +3,205%
Jane Street
4
Jane Street
New York
$23K -$776 -86 -3%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$23K – – –
National Bank of Canada
6
National Bank of Canada
Quebec, Canada
$22K +$26.2K +2,909 New
TSS
7
Two Sigma Securities
New York
$19K +$2.03K +225 +10%
SIAP
8
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$6K – – –
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$3K +$1.73K +192 +121%
Koshinski Asset Management
10
Koshinski Asset Management
Illinois
$2.52K +$3K +333 New
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Quebec, Canada
$287 – – –
Citadel Advisors
12
Citadel Advisors
Florida
– -$73K -6,095 Closed
VF
13
Virtu Financial
New York
– -$54K -4,517 Closed
EDRH
14
Edmond de Rothschild Holding
Switzerland
– -$25K -2,083 Closed
UBS Group
15
UBS Group
Switzerland
– -$9K -750 Closed
RE
16
RBC Europe
United Kingdom
– -$6 -1 Closed
Toronto Dominion Bank
17
Toronto Dominion Bank
Ontario, Canada
– +$126 +14 New
TRCT
18
Tower Research Capital (TRC)
New York
– +$226 +25 +78%

GRCE Hedge Fund Activity: Q4 2021 in Review

15 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q4 2021, worth a combined $255K — down 35% from $391K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of GRCE and 3 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 6 added.

The largest buyer was Renaissance Technologies, adding an estimated $39.7K. The largest seller was Citadel Advisors, exiting entirely with an estimated $73K sold.

  • 15 institutional investors held Grace Therapeutics (GRCE) as of Q4 2021, down from 17 in Q3 2021.
  • Funds reported $255K of Grace Therapeutics stock for Q4 2021, down 35% quarter-over-quarter.
  • 3 funds opened new Grace Therapeutics positions in Q4 2021 and 5 closed out, a net change of -2 holders.
  • The largest Grace Therapeutics buyer in Q4 2021 was Renaissance Technologies, an estimated $39.7K added.
  • The largest Grace Therapeutics seller in Q4 2021 was Citadel Advisors, an estimated $73K sold.

Based on aggregated 13F filings for Q4 2021.